Clinical Trial Update: A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis [Phase 3]

View source ↗

Summary

Phase 3 study of SPL7013 Gel (VivaGel) for treating bacterial vaginosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• SPL7013 Gel (SPL7013)

Snippet

Sponsor: Starpharma Pty Ltd | Conditions: Bacterial Vaginosis | Phase 3 | Status: COMPLETED | Results posted: 2019-07-09